🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs
5,568

Quick answer

Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Page 112 of 116

  1. OXALIPLATIN, CAPECITABINE

    Disc Medicine

    Locally advanced or metastatic gastro-intestinal carcinoma

    approved small molecule active

    1 trial

  2. Olutasidenib

    RIGEL PHARMACEUTICALS INC

    AML (Acute Myeloid Leukemia)

    approved small molecule active

    1 trial

  3. Oral prednisolone (30mg/day) for 28 days

    Hospital Authority, Hong Kong

    Esophageal Neoplasms

    approved small molecule active

    1 trial

  4. PEG-rhG-CSF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cervical Cancer

    approved small molecule active

    1 trial

  5. PEMBROLIZUMAB , NIVOLUMAB , IPILIMUMAB

    Disc Medicine

    Melanoma

    approved small molecule active

    1 trial

  6. Pegylated liposomal doxorubicin

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  7. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  8. Pluvicto 1 000 MBq/mL solution for injection/infusion

    Novartis Pharmaceuticals

    Prostate cancer

    approved small molecule active

    1 trial

  9. Pregabalin

    Pfizer

    Bone Neoplasms

    approved small molecule terminated

    1 trial

  10. RIBOCICLIB, Kisqali 200 mg film-coated tablets

    The George Institute

    Hormone receptor–positive (HRpos)/human epidermal growth factor receptor 2–negative (HER2neg) early breast cancer at risk of recurrence

    approved small molecule active

    1 trial

  11. Raltitrexed

    The First People's Hospital of Lianyungang

    Head and Neck Squamous Cell Carcinoma

    approved small molecule active

    1 trial

  12. Realgar-Indigo Naturalis Formulation Combined with Anlotinib

    The First People's Hospital of Lianyungang

    Platinum-resistant Ovarian Cancer (PROC)

    approved small molecule active

    1 trial

  13. Recombinant Human Adenovirus Type 5 injection

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    approved small molecule active

    1 trial

  14. Ribociclib

    Novartis Pharmaceuticals

    Metastatic Breast Cancer

    approved small molecule active

    1 trial

  15. S-1

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    approved small molecule active

    1 trial

  16. SELPERCATINIB, SELPERCATINIB

    Eli Lilly Co.

    Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration;

    approved small molecule active

    1 trial

  17. SIS-reinforced anastomosis

    Rocket Pharmaceuticals B.V.

    Rectal Cancer

    approved other active

    1 trial

  18. Sequential Icotinib Plus Chemotherapy

    Betta Pharmaceuticals Co.,

    EGFR Positive Non-small Cell Lung Cancer

    approved small molecule active

    1 trial

  19. Shenlingcao Oral Liquid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  20. SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation

    Ningbo Cancer Hospital

    Gastroenteropancreatic neuroendocrine tumors

    approved small molecule active

    1 trial

  21. Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial

  22. TAGRISSO 80 mg film-coated tablets

    Disc Medicine

    EGFR mutated locally advanced or metastatic non-small cell lung cancer

    approved small molecule active

    1 trial

  23. TAGRISSO 80 mg film-coated tablets

    Disc Medicine

    EGFR mutated locally advanced or metastatic non-small cell lung cancer

    approved small molecule active

    1 trial

  24. TAMOXIFEN

    Disc Medicine

    Breast cancer

    approved small molecule active

    1 trial

  25. TILMANOCEPT, TILMANOCEPT, GALLIUM (68GA) CHLORIDE, TECHNETIUM (99MTC)

    Disc Medicine

    Oral cancer

    approved small molecule active

    1 trial

  26. Talzenna 1 mg hard capsules

    Disc Medicine

    Breast cancer

    approved small molecule active

    1 trial

  27. Temozolomide

    Monte Rosa Therapeutics

    Brain Neoplasms, Malignant, Primary

    approved small molecule completed

    1 trial

  28. Thalidomide

    The First People's Hospital of Lianyungang

    Gastric Cancer

    approved small molecule active

    1 trial

  29. Tislelizumab + cisplatin + paclitaxel

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    approved small molecule active

    1 trial

  30. Toripalimab

    Coherus Oncology

    Nasopharyngeal Cancer Recurrent

    approved small molecule active

    1 trial

  31. Tramadol HCI/acetaminophen

    Janssen-Cilag Pty Ltd

    Cancer

    approved small molecule completed

    1 trial

  32. Trastuzumab Rezetecan

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  33. Vemurafenib

    Hoffmann-La Roche

    Neoplasms

    approved small molecule completed

    1 trial

  34. Venetoclax

    AbbVie

    Acute Myeloid Leukemia (AML)

    approved small molecule active

    1 trial

  35. Xiang Sha Liu Jun Zi Decoction dry powder

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule completed

    1 trial

  36. Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets

    Bayer AG

    metastatic castrate resistant prostate cancer (mCRPC)

    approved small molecule active

    1 trial

  37. Xtandi - 40 mg soft capsules

    The George Institute

    PROSTATE CANCER

    approved small molecule active

    1 trial

  38. aspirin and/or clopidogrel

    Takeda

    Early Gastric Cancer

    approved small molecule active

    1 trial

  39. crizotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Anaplastic Large-Cell Lymphoma

    approved small molecule terminated

    1 trial

  40. dabrafenib

    Novartis Pharmaceuticals

    Melanoma

    approved small molecule active

    1 trial

  41. docetaxel

    Hoffmann-La Roche

    Breast Cancer

    approved small molecule completed

    2 trials

  42. first-line scheme+compound kushen injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Colorectal Carcinoma

    approved small molecule active

    1 trial

  43. inotuzumab ozogamicin-dose level 2

    Pfizer

    Leukemia

    approved small molecule completed

    1 trial

  44. neoadjuvant therapy

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma Resectable

    approved other active

    1 trial

  45. silk suture

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    approved other completed

    1 trial

  46. temsirolimus

    Pfizer

    Non-Hodgkin's Lymphoma

    approved small molecule completed

    1 trial

  47. trastuzumab [Herceptin]

    Hoffmann-La Roche

    Gastric Cancer

    approved small molecule terminated

    1 trial

  48. 18F-FDG

    The First People's Hospital of Lianyungang

    Tumor, Solid

    other completed

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.